Cairns & Hinterland Hospital & Health Service QLD

CHHHS131240

Thursday 02 April 2026 (E. Australia Standard Time)

Friday 15 May 2026 02:00 PM (E. Australia Standard Time) CLOSED

Friday 15 May 2026 02:00 PM (E. Australia Standard Time)

Monday 30 November 2026 (E. Australia Standard Time)

Cairns & Hinterland Hospital & Health Service QLD

85 Spence St
Portsmith, Queensland 4870
Australia

https://www.cairns-hinterland.health.qld.gov.au/

Cairns and Hinterland Hospital and Health Service covers an area of 142,900 square kilometres. We go as far as Tully in the south, Cow Bay in the north and Croydon in the west.

The buyer has elected to have their personal and contact details hidden. These details will be revealed at the buyers discretion.

Cairns and Hinterland Hospital and Health Service (CHHHS) is seeking Expressions of Interest (EOI) from suitably qualified suppliers to inform the development of a commercial model for the provision of smart intravenous (IV) infusion technology, under a nil-capital consumables index with a defined baseline pricing schedule and commercial controls governing pricing, and lifecycle obligations.

This EOI will assist CHHHS in determining a fit-for-purpose, compliant, and financially sustainable procurement methodology that ensures clinical safety, interoperability, and long-term value for money. Market sounding will inform commercial options resulting in either direct negotiation or subsequent Invitation to Offer (ITO).

Goods / Services Required

- Supply of volumetric and syringe smart IV infusion pumps, including associated hardware, drug libraries and provision of consumables (e.g. administration sets and related disposables)

- A nil-capital, consumables-linked commercial model, where equipment costs are amortised through consumables pricing

- Defined baseline pricing schedule with transparent standalone consumables pricing and commercial controls (e.g. indexation, benchmarking, lifecycle obligations)

- Integrated drug library software, connectivity, and cybersecurity updates in accordance with QICT

- Maintenance, servicing, training, and lifecycle management


Delivery Location

- Primary delivery and implementation will occur across Cairns and Hinterland Hospital and Health Service (CHHHS) facilities in Far North Queensland

- Elements of the service (e.g. software support, monitoring, updates) may be delivered in accordance with QICT and CHHHS requirements

Expected Timing

EOI release: 02/04/2026

Market engagement and evaluation: May 2026

Anticipated procurement progression (negotiation or ITO): Following EOI outcomes

Implementation commencement: Subject to procurement outcome and approvals

Key Commercial Outcome

The proposed model is a consumables-linked arrangement whereby:

- No upfront capital expenditure is incurred by CHHHS

- Equipment costs are amortised over the contract term

- Suppliers assume lifecycle obligations (maintenance, upgrades, compliance)

- At contract end, CHHHS will either retain ownership of the pumps or transition to a technology refresh under a new agreement

Cairns and Hinterland Hospital and Health Service (CHHHS) is undertaking a strategic procurement of smart intravenous (IV) pump technology to replace and standardise its existing fleet, which is approaching end-of-life and exhibits variability in models, functionality, and interoperability. This procurement aligns with Queensland Health’s broader digital health and patient safety strategies, including medication safety, closed-loop medication management, and integration with enterprise electronic medical records (ieMR). The current Standing Offer Arrangement (SOA QH030) supports outright purchase only and does not accommodate alternative commercial models such as leasing or consumables-linked arrangements, necessitating a revised procurement approach.

The proposed procurement is being progressed in parallel with other digital and clinical uplift initiatives, including medication management system enhancements, cybersecurity uplift programs, and biomedical asset standardisation. These concurrent projects introduce interdependencies, particularly in relation to ICT integration, data governance, and clinical workflow alignment. CHHHS operates within a highly regulated environment, subject to Queensland Procurement Policy 2026, Queensland Treasury Financial Accountability frameworks (including AASB 16 lease considerations), Human Rights Act 2019 (Qld), and ICT security and interoperability standards mandated by Queensland Health.

CHHHS has a strong focus on clinical safety whilst ensuring value-for-money procurement, risk mitigation, and lifecycle asset management, with increasing emphasis on innovative commercial models that reduce upfront capital expenditure while maintaining transparency and audit compliance. Lessons learned from prior capital-intensive medical equipment procurements highlight the importance of robust financial modelling, clear contractual allocation of lifecycle obligations. Market engagement through an Expression of Interest (EOI) will be critical to validate the feasibility of a consumables-linked model and ensure alignment with both clinical and financial governance requirements.

Technical Specifications and Requirements

The required solution comprises volumetric and syringe smart IV infusion pumps, including all associated hardware, software, consumables, and supporting infrastructure necessary for safe and effective operation within CHHHS clinical environments.

The IV pump system must support interoperability with existing Queensland Health digital ecosystems, including integration with the integrated electronic Medical Record (ieMR), medication management systems, and relevant clinical decision support tools. This includes compatibility with HL7/FHIR messaging standards, secure network connectivity (wired and/or wireless), and alignment with Queensland Health cybersecurity and ICT architecture requirements. Devices must support centralised drug library management, with the ability to update and deploy drug libraries across the fleet in real time, ensuring compliance with medication safety protocols.

All pumps must include Dose Error Reduction Systems (DERS), configurable drug libraries, and support for continuous quality improvement through data capture and reporting capabilities. The system must enable integration with barcode medication administration (BCMA) workflows and support closed-loop medication management where applicable.

The specifications attached to this EOI include but are not limited to;

- Volumetric and syringe pump configurations suitable for adult, paediatric, and neonatal care settings

- High accuracy infusion delivery with configurable alarm parameters and fail-safe mechanisms

- Battery performance sufficient to support clinical mobility requirements and power outage scenarios

- Full lifecycle inclusions under the commercial model, including preventative maintenance, calibration, battery replacement, firmware/software updates, cybersecurity patching, and technical support

- Hosting requirements (cloud or on-premises) compliant with Queensland Government data security classifications (ICT questionnaire included)

- Fleet management capability, including asset tracking, utilisation reporting, and remote diagnostics

- Scalability to support future expansion across CHHHS facilities

- HHS project implementation and training

Associated dependent components include:

- Proprietary or compatible consumables (e.g. infusion sets, syringes), which must be clearly specified and priced transparently on a standalone basis

- Docking stations, mounting systems, and transport accessories compatible with existing clinical infrastructure (e.g. bed rails, IV poles)

- Network infrastructure requirements, including bandwidth, Wi-Fi coverage, and device authentication protocols

- Integration interfaces with existing biomedical engineering systems and asset management platforms

All products must comply with relevant Australian regulatory requirements, including Therapeutic Goods Administration (TGA) approval, and align with applicable Australian Standards for medical equipment. Suppliers must demonstrate the ability to support ongoing technology refresh and ensure devices remain clinically current over the contract term without requiring significant additional capital investment and ensure successful project implementation and training.

• Queensland
  1: Far North

All Regions of Service locations are within Australia.

Please note: The following addendum has been recently added.

1. Added: (Addendum) Addendum 1.pdf

Please consider this addendum when responding.

Please note: The following addendum has been recently added.

1. Added: (Addendum) Addendum 2.pdf

Please consider this addendum when responding.

Please note: The following attachment has been recently added.

1. Added: BLANK DRAFT Contract Details Part B.pdf

Please consider this attachment when responding.

Submission Deadline Extension

An extension is granted.

The original closing date of Friday 1 May 2026 is extended to:

NEW CLOSING DATE:

2:00pm Friday 15 May 2026

Please note: The following attachment has been recently added.

1. Added: BLANK DRAFT Contract Details Part B.pdf

Please consider this attachment when responding.